ABCG1 promotes the proliferation and migration of clear cell renal cell carcinoma and reduces its apoptosis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.ATP-binding cassette transporter G1 (ABCG1) is elevated in clear cell renal cell carcinoma (ccRCC), impacting progression. Reduced ABCG1 inhibits ccRCC cell growth and invasion, suggesting its potential as a diagnostic and prognostic biomarker.
Area Of Science
- Oncology
- Molecular Biology
- Biochemistry
Background
- Clear cell renal cell carcinoma (ccRCC) is a significant health concern.
- Understanding the molecular mechanisms driving ccRCC progression is crucial for developing effective treatments.
- ATP-binding cassette transporter G1 (ABCG1) is a key player in cellular lipid metabolism and has been implicated in various cancers.
Purpose Of The Study
- To investigate the expression levels of ABCG1 in ccRCC.
- To assess the significance of ABCG1 in the early diagnosis and prognosis of ccRCC.
- To elucidate the role of ABCG1 in ccRCC biological processes and its impact on cell function.
Main Methods
- Analysis of ABCG1 expression using The Cancer Genome Atlas (TCGA) database, immunohistochemical staining, and western blot.
- Correlation analysis of ABCG1 expression with clinicopathological stage and prognosis in ccRCC patients.
- Functional experiments using ABCG1 stable knockout cell lines and inhibitors to assess effects on ccRCC cell proliferation, migration, invasion, and apoptosis.
- RNA-sequencing (RNA-seq) to identify pathways and genes affected by ABCG1.
Main Results
- ABCG1 expression was significantly elevated in ccRCC tissues compared to normal tissues.
- Elevated ABCG1 levels correlated with advanced clinicopathological stage and poorer prognosis in ccRCC.
- Reduced ABCG1 expression suppressed ccRCC cell proliferation, migration, and invasion, while enhancing apoptosis.
- RNA-seq analysis revealed that ABCG1 positively regulates proliferation-associated genes and negatively impacts apoptosis-associated genes.
Conclusions
- ABCG1 plays a critical role in the progression of ccRCC.
- ABCG1 serves as a potential independent prognostic marker for ccRCC.
- Targeting ABCG1 may offer a therapeutic strategy for ccRCC.
- ABCG1 holds promise as a biomarker for ccRCC diagnosis and prognosis.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...